title: Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
authors.affiliation: Massey Cancer Center, Virginia Commonwealth University, Medical College of Virginia, Richmond, USA. john.d.roberts@vcu.edu
authors.forename: John D
authors.initials: JD
authors.lastname: Roberts
authors.forename: Mitchell R
authors.initials: MR
authors.lastname: Smith
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Feldman
authors.forename: Louise
authors.initials: L
authors.lastname: Cragg
authors.forename: Steven
authors.initials: S
authors.lastname: Grant
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D054713:Bryostatins; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D018942:Macrolides; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D054713:Bryostatins; D007783:Lactones; D018942:Macrolides; C046785:bryostatin 1; D014740:Vidarabine; C024352:fludarabine